Water transport in the kidney and nephrogenic diabetes insipidus

Journal of Veterinary Internal Medicine

Volumn 16, Issue 5, 2002, Pages 510-517

  Cohen, Michele ^a   Post, Gerald S ^b  

^a AUBURN UNIVERSITY   (United States)

^b Vet Oncology and Hematology Center   (United States)

Author keywords

Aquaporin; Hyperosmolanty; Vasopressin

Indexed keywords

VASOPRESSIN DERIVATIVE; WATER;

ANIMAL; ANIMAL DISEASE; HUMAN; KIDNEY; METABOLIC DISORDER; METABOLISM; NEPHROGENIC DIABETES INSIPIDUS; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; DIABETES INSIPIDUS, NEPHROGENIC; HUMANS; KIDNEY; VASOPRESSINS; WATER; WATER-ELECTROLYTE IMBALANCE;

EID: 1842832673     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2002.tb02379.x     Document Type: Review

References (83)

1. Oksche A. Rosenthal W. The molecular basis of nephrogenic diabetes msipidus J Mol Med 1998;76:326-337.
2. Birnbaumer M. Vasopressin receptors. TEM 2000;11:406-410.
3. Terris J, Ecelbarger CA, Marples D, et al. Distribution of aquaponn-4 water channel expression within rat kidney. Am J Physiol 1995;269 F775-F785
4. Birnbaumer M Vasopressin receptor mutations and nephrogenic diabetes insipidus Arch Med Res 1999;30:465-474.
5. Taylor SM. Polyuria and polydipsia In: Ettinger SJ. Feldman EC, ed. Textbook of Veterinary Internal Medicine, 5th ed. Philadelphia, PA: WB Saunders: 2000:85.
6. Bichet DG. Nephrogenic diabetes msipidus. Semin Nephrol 1994;14:349-356.
7. 2 receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature. Endocrinology 1994;135:1511-1528.
8. 1b vasopressin receptor. J Biol Chem 1994;269:27088-27092.
9. DeKeyzer Y. Auzan C, Lenne F, et al. Cloning and characterization of the human V3 pituitary Vasopressin receptor. FEBS Lett 1994: 356:215-220
10. 1b Vasopressin receptor gene. Proc Natl Acad Sci USA 1995;92L:200-204.
11. Lee D, King L. Agre P. The aquaporin family of water channel proteins in clinical medicine. Medicine 1997;76:141-156.
12. King L, Yasui M, Agre P. Aquaporins in health and disease. Mol Med Today 2000:6 60-65.
13. Van Os CH, Kamsteeg EJ, Marr N, et al. Physiologic relevance of aquaporins: Luxury or necessity? Eur J Physiol 2000;440:513-520.
14. Knepper MA, et al. Renal aquaporins. Kidney Int 1996;49: 1712-1717.
15. Sansom MS, Law RJ. Aquaporins - Channels without ions. Curr Biol 2001;11:R71-R73.
16. Heyman JB. Engel A Aquaporins. Phylogeny, structure, and physiology of water channels. News Physiol Sci 1999;14:187-193.
17. Borgnia M, Nielsen S, Engel A, Agre P Cellular and molecular biology of the aquaporin water channels. Annu Rev Biochem 1999; 68:425-428.
18. Nielsen S. Smith BL, Christensen EI. et al CHIP28 water channel are localized in constitutively water-permeable segments of nephron. J Cell Biol 1993;120:371-383.
19. Nielsen S, Pallone T, Smith BL, et al. Aquaporin-1 water channels in short and long loop descending thin limbs and m descending vasa recta in rat kidney. Am J Physiol 1995;268:F1023-F1037.
20. Knoers NV, van Os CH. The clinical important of the urinary excretion of aquaporin-2. N Engl J Med 1995;332:1575-1576.
21. Deen PM, Verdijk MA. Knoers NV. et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994;264:92-95.
22. Connelly DL, Shanahan CM, Weissberg PL. The aquaporins. A family of water channel proteins. Int J Biochem Cell Biol 1998;30: 169-172.
23. Fushimi K. Aquaporin-2 vasopressin water channel. Clin Exp Nephrol 1999;3:154-158.
24. Fushimi K, Uchida S, Hara Y, et al. Cloning and expression of apical membrane water channel of rat-kidney collecting tubule. Nature 1993;361:12549-12552.
25. Marples D, Frokiaer J, Nielsen S. Long-term regulation of aquaporins in the kidney. Am J Physiol 1999;276:F331-F339.
26. Brown D, Cunningham C, Hartwig J. Association of AQP2 with actm in transfected LLC-PK1 cells and rat papilla. J Am Soc Nephrot 1996;7:1265 (abstract).
27. Ding G, Franki RM, Condelia J. Vasopressin depolymenzes F-actin in toad bladder epithelial cells. Am J Physiol 1991;260:C9-C16.
28. Simon H. Gao Y, Franki N. Vasopressin depolymenzes apical F-actm in rat inner medullary collecting duct. Am J Physiol 1993;265: C757-C762.
29. Marples D, Schroer TA, Ahrens H, et al. Dynein and dynactin colocalize with AQ2 water channels in intracellular vesicles from kidney collecting duct. 1998.
30. Mulders S, van Lieburg, AF, Monnens LA, et al. Physiology and pathophysiology of aquaporins. Eur J Clin Invest 1996;26:1041-1050.
31. Ecelbarger C, Terris J, Frindt G, et al. Aquaporin-3 water channel localization and regulation in rat kidney. Am J Physiol 1995;269: F663-F672.
32. Terris J, Ecelbarger CA, Marples D. et al. Distribution of aquaporin-4 water channel expression within rat kidney. Am J Physiol 1995;269:F775-F785.
33. Ma T, Song Y, Yang B, et al. Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels. Proc Natl Acad Sci USA 2000;97:4386-4391.
34. Yasui M. Kwon TH, Knapper MA, et al. Aquaporin-6: An intracellular vesicle water channel protein in renal epithelia. Proc Nail Acad Sci USA 1999;96:5808-5813.
35. Yasui M, Hazama A, Kwon TH, et al. Rapid gating and anion permeability of an intracellular aquaporin. Nature 1999;402:184-187.
36. Martin PY, Schrier RW. Role of aquaporm-2 water channels in urinary concentration and dilution defects. Kidney Int 1998;53.557-562.
37. DiGiovanni SR, Nielsen S, Christensen EL, et al. Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat Proc Natl Acad Sci USA 1994;91:8994-8999.
38. Uchida S, Sasaki S, Fushimi K, et al. Isolation of human aquaporin-CD gene. J Biol Chem 1994;269:23451-23455.
39. Feldman EC, Nelson RW. Water metabolism and diabetes insipidus. In: Feldman EC, Nelsen RW. ed. Canine and Feline Endocrinology and Reproduction, 2nd ed. Philadelphia. PA: WB Saunders; 1996:14-15.
40. Deen PM, Croes H, van Aubel RA, et al. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are unpaired in their cellular routine. J Clin Invest 1995;95:2291-2296.
41. Hamilton KL, Butt GA. The molecular basis of renal tubular transport disorders. Comp Biol Physiol 2000; 126(Part A):305-321.
42. Knoers NV. Molecular characterization of nephrogenic diabetes insipidus. Trends Endocrinol Metab 1994;5:422-428.
43. Fujiwara TM, Morgan K. Bichet DG. Molecular analysis of X-linked nephrogenic diabetes insipidus. Eur J Endocrinol 1996; 134: 675-677.
44. Bichet D, Oksche A, Rosenthal W. Congenital nephrogenic di abetes insipidus. J Am Soc Nephrol 1997;8:1951-1958.
45. Rutishauser J, Kopp P. Aquaporin-2 water channel mutations and nephrogenic diabetes insipidus: New variations on a theme. Eur J Endocrinol 1999;140:137-139.
46. Braun EJ, Stallone JN. The occurrence of nephrogenic diabetes insipidus in domestic fowl. Am J Physiol 1989;256:F639-F645.
47. Frokiaer J, Marples D, Valtin H, et al. Low aquaporin-2 levels in polyuric DI +/+ severe mice with constitutively high cAMP-phosphodiesterase activity. Am J Physiol 1999;276:F179-F190.
48. Takemura N. Successful long-term treatment of congenital nephrogenic diabetes insipidus in a dog. J Small Anim Pract 1998;39: 592-594.
49. Grunbaum EG, et al. Genetisch bedingter diabetes insipidus renalis beim hund. 35th Annual Meeting, Deutsche Veterinarmedizinische Gesellschaft DVG, Fachgeruppe Kleinticrkrankheiten, DVG, GieBen FRG; 1990.
50. Schott HC, Bayly WM, Reed SM, et al. Nephrogenic diabetes insipidus in sibling colts. J Vet Intern Med 1993;7:68-72.
51. Marples D, Frokiar J, Knepper MA, et al. Disordered water channel expression and distribution in acquired nephrogenic diabetes insipidus. Proc Assoc Am Physiol 1998;110:401-406.
52. Marples D, Frokiaer J, Dorup J, et al. Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest 1996;97:1960-1968.
53. Gray EJ, Dierks EJ. Lithium-induced diabetes insipidus in a surgical patient: Report of a case and review of the literature. J Oral Maxillofac Surg 1996;54:909-912.
54. Sands JM, Naruse M, Baum M, et al Apical extracellular calcium/polyvalent cation sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct J Clin Invest 1997;99:1399-1405.
55. Frokiaer J, Marples D, Knepper MA, Nielsen S. Bilateral ureteral obstruction downregulates expression of vasopressin-sensitive AQP-2 water channel in rat kidney. Am J Physiol 1996;270(4 Part 2): F657-F668.
56. Tcitelbaum I, McGuinness S. Vasopressin resistance in chronic renal failure. J Clin Invest 1995;96:378-385.
57. Joies JA, Gruys E. Nephrogenic diabetes insipidus in a dog with renal medullary lesions. J Am Vet Med Assoc 1979;174:830-834.
58. Feibush J, Barbosa-Saldivar JL, Bernstein RS. Tumor-associated nephrogenic diabetes insipidus. Ann Intern Med 1980;92:797-798.
59. Cohen M, Post GS. Nephrogenic diabetes insipidus in a dog with intestinal leiomyosarcoma. J Am Vet Med Assoc 1999;215:1818-1820.
60. Kamoi K, Hama H, Ito S, et al. Immune complexes in diabetes insipidus of rabbits immunized with vasopressin. Endocrinol Jpn 1977, 24:239-243.
61. Breslow E. Walter R. Binding properties of bovine neurophysins I and II: An equilibrium dialysis study. Mol Pharmacol 1972;8: 75-81.
62. Chan WY, Hruby VJ, Flouret G, et al. 4-Leucine-oxytocin, natriuretic, diuretic, and antivasopressin polypeptide. Science 1968;161: 280-281.
63. Datta H, Chaudhury RR. The antidiuretic hormone blocking effect of some oxytocin analogues. J Endocrinol 1968;42:345-346.
64. Dousa T, Hechter O, Walter R, et al. [8-Arginine]-vasopressinoic acid: An inhibitor of rabbit kidney adenyl cyclase. Science 1979; 167:1134-1135.
65. Anderson PJ, Berl T, McDonald KM, et al. Prostaglandins: Effects on blood pressure, renal blood flow, sodium and water excretion. Kidney Int 1976;10:205-215.
66. Deen PM, van Aubel RA, van Lieburg AF, et al. Urinary content of aquaporin 1 and 2 in nephrogenic diabetes insipidus. J Am Soc Nephrol 1996;7:836-841.
67. Feldman EC, Nelson RW. Diagnostic approach to polydipsia and polyuria. Vet Clin North Am 1989;19:327-341.
68. Kirchlechner V, Koller DY, Seidl R, Waldhauser F. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride Arch Dis Childhood 1999;80:548-552.
69. Usberti M, Dechaux M, Guillot M, et al Renal prostaglandin E, in nephrogenic diabetes insipidus. J Pediatr 1980;97:476-478.
70. Hohler T. Teuher G, Wanitschke R. Meyer zum Buschenfeld KH. Indomethacin treatment in amphotericm B induced nephrogenic diabetes insipidus. Clin Invest 1994;72:769-771.
71. Schoneberg T. Yun J, Wenkert D, et al Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a coexpressed receptor polypeptide. EMBO 1996;15:1283-1291.
72. Schoneberg T, Sandig V, Weiss J. et al. Reconstitution of mutant V2 vasopressin receptors by adenovinis-mediated gene transfer. J Clin Invest 1997;100:1547-1556
73. Tamarappoo BK, Verkman AS. Defective aquaporin-2 trafficking in nephrogenic diabetes msipidus and correction by chemical chaperones. J Clin Invest 1998;101:2257-2267.
74. Stevens S, Brown BD, McGahan JP. Nephrogenic diabetes insipidus: A cause of severe nonobstructive urinary tract dilatation. Proc Ultrasound Med 1995;14:543-545.
75. Hong EG, Suh Y, Chung YS, et al. A case of nephrogenic diabetes insipidus caused by obstructive uropathy due to prostate cancer. Yonsei Med J 2000;41:150-154.
76. Fujii T. Ochi J, Miyajima T. et al Nephrogenic diabetes insipidus and tethered cord syndrome with a lipoma of the cauda equina. Brain Dev 1998;20:47-49.
77. Vasey PA, Dunlop DJ, Steward WP. Nephrogenic diabetes insipidus following high dose epirubicin chemotherapy for metastatic soft tissue sarcoma. Eur J Cancer 1995;31A:126-127.
78. Fernandez-Llama P, Andrews P, Nielsen S, et al. Impaired aquaporin and urea transporter expression in rats with adriamycin-induced nephrotic syndrome Kidney Int 1998;53 1244-1253.
79. Navarro JF, Quereda C, Quereda C, et al. Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet. Am J Kidney Dis 1996;3:431-434.
80. Skinner R, Pearson AD, Martin W, et al. Risk factors for ifosfamide nephrotoxicity in children. Lancet 1996;348:578-580.
81. Schliefer K, Rockstroh JK, Spengler U, Sauerbruch T. Nephrogenic diabetes insipidus in a patient taking cidofovir. Lancet 1997; 350:1558.
82. Conn J. Colman P. Brown G, et al. Nephrogenic diabetes msipidus associated with foscarnet - A case report. J Antimicrob Chemother 1996;37:1179-1181.
83. Buridi A, Corman L, Redinger R. Hypokalemic nephropathy and nephrogenic diabetes insipidus due to excessive consumption of a soft dnnk. South Med J 1998;91:1079-1082.